This case pairs R21 virus-like particles with Matrix-M and age-based low doses to sustain immunity while reducing reactogenicity.
Labeled PERV-B RBD ligands bind SMVT on cell surfaces for diagnostic measurement in biological samples.
This case uses miR-124 targets in essential HSV genes to limit normal-brain replication while retaining tumor-cell lysis.